FDA: AUC0–72 [Regulatives / Guidelines]

posted by Mahesh M – India, 2015-12-29 14:51 (3374 d 02:35 ago) – Posting: # 15774
Views: 9,724

Dear Helmut,

Thank you so much for your explanation.

❝ #2 is strange. Where would one get the X and Y from?


Can we use our pilot study data (CV % for partial AUC from pilot study) to support truncated design in pivotal study.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,713 registered users;
25 visitors (0 registered, 25 guests [including 6 identified bots]).
Forum time: 17:27 CET (Europe/Vienna)

It’s easy to lie with statistics;
it is easier to lie without them.    Frederick Mosteller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5